Just picked the article below, any impact on Avexa ??
Partnership Covers Generics and Differentiated Formulations
HYDERABAD, India--(BUSINESS WIRE)--Jun 15, 2009 - Dr. Reddy's Laboratories (NYSE: RDY) today announced a partnership with GlaxoSmithKline plc (GSK) to develop and market select products across emerging markets outside India.
Under the terms of the agreement, which is effective immediately, GSK will gain access to Dr. Reddy's rich and diverse portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management.
Add to My Watchlist
What is My Watchlist?